Walmart Inc. Issues Voluntary Nationwide Recall of Various Artri Ajo King Joint Supplements Due to Potential Hidden Drug Ingredients | FDA

2022-06-10 23:57:09 By : Mr. Amy Chen

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Walmart Inc. is voluntarily recalling all lots of Artri Ajo King Joint Supplements sold by Innovacion Naturals and PDX Supply Warehouse LLC on Walmart.com and shipped by Walmart to the consumer level. FDA laboratory analysis confirmed that Artri Ajo King Omega 3 Joint Support Supplement with LOTE LTARTKNGOMG30720, CADUCIDAD DICIEMBRE 2026, UPC 7 501031 111190 contains diclofenac not listed on the product label

Diclofenac is a non- steroidal anti-inflammatory drug commonly referred to as NSAIDs. NSAIDs (nonsteroidal anti-inflammatory drugs) may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID- containing products.

These products are marketed as dietary supplements and used for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

Walmart has notified customers by email or mail who purchased the above products from third- party sellers on Walmart.com and shipped by Walmart. Customers taking these products should immediately talk to their health care provider to safely discontinue use of the product because suddenly stopping diclofenac may be dangerous.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

More Recalls, Market Withdrawals, & Safety Alerts